PALM BEACH GARDENS, FL--(Marketwired - July 28, 2014) - The Radiant Creations Group, Inc. ("Radiant") (RCGP), developer of unique, proprietary scientific technologies and cosmetic and over-the-counter products and devices, is pleased to announce at its regularly scheduled Board meeting held on July 3, 2014 the Directors agreed to "spinoff" the Company's exclusive license agreement with Dr. Yin-Xiong Li, MD, Ph.D. The new Company name will be NIT Enterprises, Inc. (Nucleotide Industrial Technologies). The Exclusive license agreement includes patented and patent-pending technologies for the development of innovative nucleotide technologies or nucleic acid (NA) code molecules, applications for the technologies to be directed at industrial facilities, medical facilities, hospitals, the welding industry and military and homeland security markets.
Nucleotides are any of a group of molecules that, when linked together, form the building blocks of DNA or RNA: composed of a phosphate group, the bases adenine, cytosine, guanine, and thymine, and a pentose sugar. ("http://dictionary.reference.com/browse/nucleotide")
After a decade and a half of intense genetic research by Dr. Yin-Xiong Li, MD, Ph.D., the true capability of nucleic acid code molecules were discovered and brought to a commercially exploitable state through one granted patent and one applied patent, to be exclusively licensed to NIT.
Gary Smith, CEO, Radiant, stated, "This discovery ranks as one of the most profound and valuable discoveries for almost limitless technological enhancement in industrial, medical and the chemical development. The potential revenues to be generated by commercialization of these exclusive NA technologies can be exploited through manufacturing NA as a raw material, and licensing production for a myriad of applications which are also expected to generate significantly more intellectual property enhancements."
Radiant's exclusive license included documentation that concluded, NA free of the DNA ladder has been shown to protect against the harmful effects of Ultraviolet light (UV) radiation across a wide band of UV spectrum. NA performs its unique function when it is free to react with photons and UV rays. When a damaging UV photon hits a freed NA molecule, it is absorbed and then re-emitted as a harmless infrared (heat) photon into the atmosphere. The NA may remain undamaged and continues to perform its protective function.
Proposed applications and future testing to include identifying methods to enhance protection from ionizing radiation such as X-Rays and Gamma Rays providing NIT with effective solutions to reduce the impact of radiation, thus creating a market for protecting government and institutional public buildings, hospitals, clinics, dentist and doctor's offices and industrial facilities; anywhere there is use of ionizing radiation.
Shareholders of record of The Radiant Creations Group, Inc. (RCGP) will receive (proportionally) shares of NIT Enterprises, Inc. following the completion and effectiveness of the required SEC filings. The Company will announce the Record date for the issuance of "spinoff" shares upon completion of required legal compliance.
About The Radiant Creations Group, Inc. (RCGP) (www.radiantcreations-rcgp.com)
Radiant Creations has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA derived technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed never before used in western culture by any bioscience company.
Among these exciting discoveries is a new and superior mechanism of defense against skin deterioration and damage caused by sun exposure to ultraviolet (UV) light using the nucleotides, four "code molecules" extracted from DNA. This revolutionary mechanism also has great significance and value in many other cosmetic and non-cosmetic applications requiring UV protection, and is among Radiant Creations' licensed intellectual property. The technology will be implemented across numerous innovative product lines.
About NIT Enterprises, Inc. (NIT) (www.NITEnterprises.com)
NIT Enterprises, Inc. (d/b/a Nucleotide Industrial Technologies) (NIT) was created to improve public safety and to provide a new measure of protection for commercial, industrial, and personal products that enhance the longevity of living and non-living substances based upon unique proprietary NA technologies developed by our award winning scientist and technology team. This new technology is the infusion of ingredients, known as nucleotides, into a multiplicity of common products enhanced by their presence. The Nucleotides were derived by atomic level research that demonstrates their ability to provide Ultraviolet (UV) rays screening capability at the molecular level.
Cautionary Statement Concerning forward-Looking Statements:
This press release contains forward-looking statements that can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.